News Sentiment

EMCURE sentiment intelligence

EMCURE PHARMACEUTICALS L news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 18 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1814.40 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

74/100 classification confidence.

Company focus 18

directly relevant articles

Source quality 9

high-authority source matches

Trend context Trend active

-1.3% over one week, +4.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Emcure Pharmaceuticals to discuss Q1 FY27 results on August 6

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 74/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend active 4.5% over four weeks
Fair value 31.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 12
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 18
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Moneycontrol.com 4
scanx.trade 3
CNBC TV18 2
simplywall.st 2
outlookbusiness.com 1
Business Standard 1
The Economic Times 1
ad-hoc-news.de 1

Event Lens

What the news is about

Classified themes
Market update 7
Deals and strategy 6
Earnings 3
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-18 of 18